Thought Leadership: Healthcare

Handle DSCSA's Full Implementation Like An Expert

Let’s face it. The Drug Supply Chain Security Act (DSCSA) is demanding changes to your business, and some of them will be extremely complex. Now is the time to evaluate your organization’s progress toward compliance — and take charge of completing all the necessary steps before full implementation. The good news? We’re here to help you navigate the DSCSA labyrinth. 

• Read more about Handle DSCSA's Full Implementation Like An Expert

The Supreme Court Ruling: Our Responsibility to our U.S. Associates

Last week’s Supreme Court healthcare ruling had profound implications for many of our associates and we feel it is our responsibility to ensure that all Inmar associates are treated fairly and equally.

• Read more about The Supreme Court Ruling: Our Responsibility to our U.S. Associates

Is Inflation Cutting Health from Shopper’s Budgets?

As COVID-19 concerns decrease, a separate issue is on the rise — and having its own (unexpected) impact on healthcare. Inflation.

• Read more about Is Inflation Cutting Health from Shopper’s Budgets?

EPA REGULATIONS AND COMPLIANCE IS CHANGING IN JULY

Managing hazardous pharmaceutical waste compliance is critical to your healthcare facility, but so is making sure staff have time to focus on their patients. With already complex federal and state regulations constantly changing, it might be difficult for your healthcare facility to balance those duties. You can’t afford to sacrifice either one, so what’s the best course of action?

• Read more about EPA REGULATIONS AND COMPLIANCE IS CHANGING IN JULY

Medical Recalls: Not “If” but “When”

*/ /*-->*/ Whether it’s for devices, supplies, or pharmaceuticals, eventually your hospital system will be impacted by a recall. The best way to prepare is to make certain your health system knows as much about those events as possible. And immediately. Any delay could lead to patient or staff injury. Or worse.

• Read more about Medical Recalls: Not “If” but “When”

DSCSA 2023 — What You Need to Know About Staying Compliant

As we approach the final stage of our industry’s 10-year implementation of the Drug Supply Chain Security Act (DSCSA), Inmar Intelligence remains committed to keeping the healthcare community informed — so you can achieve DSCSA compliance. 

• Read more about DSCSA 2023 — What You Need to Know About Staying Compliant

Community Makes Consumer Drug Take-Back Day a Success

Did you participate in National Prescription Drug Take-Back Day? We hope so! Inmar Intelligence hosted our third Consumer Drug Take-Back event in conjunction with the Winston-Salem Police Department on October 23rd. These Take-Back days provide a convenient and safe way to dispose of unused medications and a chance to help make our communities safer. Every participant is helping us bring awareness to the problem of surplus prescription drugs in our communities.

• Read more about Community Makes Consumer Drug Take-Back Day a Success

Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Half a million pounds. It sounds like a lot, but how much is it? Half a million pounds is equivalent to two and a half blue whales, a 2,500 square foot home or a locomotive engine. That’s how much unwanted medication we’ve collected through the placement of 4,000 kiosks with the Consumer Drug Take-Back program.

• Read more about Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal

This year, overdose deaths increased 30% in the US, reaching the highest rate in our country’s history. That means, on average, over 260 Americans die every day from a drug overdose, according to the CDC. This persistent (and increasing) problem demands new solutions. Inmar surveyed 1,000 adults across the US to understand how they’re personally impacted by prescription drug misuse, and to gauge their awareness of proper disposal options.

• Read more about Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal